Delirium high in ICU patients, leads to death, morbidity

There are an estimated 6,000 intensive care units in the United States caring for approximately 55,000 patients daily. Between 60 percent to 80 percent of these patients develop a brain dysfunction known as delirium, which according to a group of physicians at Vanderbilt Medical Center is an independent predictor of mortality.

In the April 14 issue of "The Journal of the American Medical Association," E. Wesley Ely, M.D., associate professor of Medicine and Research, and his team provided the first documented study to include daily measurements of delirium in the Intensive Care Unit, pointing to longer hospital stays and a three-fold increase in death.

"The dilemma in critical care is that people often develop brain dysfunction or delirium in the ICU setting which is thought to be of no real importance to survival or long-term quality of life," Ely said. "Frankly, it's been overlooked by medical teams for years and is simply called 'ICU psychosis.'"

"Five years ago, we began studying delirium in the ICU at Vanderbilt, after realizing that older people are more frequently going to ICUs and the added risk of developing brain dysfunction was present."

The JAMA piece titled "Delirium as a Predictor of Mortality in Mechanically-Ventilated Patients in the Intensive Care Unit" is a culmination of the work to date, Ely said.

"We have found that using the most robust statistical methods available to adjust for the severity of illness, age, coma and drugs used for sedation, the development of delirium presents the patients with a 300 percent increased likelihood of dying by six months as compared to similar patients who didn't develop delirium," Ely said.

"All of this work is ultimately leading us down the path of delirium prevention and treatment," he said. "Right now there are no data from randomized trials proving the best treatment. Secondly, delirium is grossly under-recognized so even if we knew how to treat it, nurses and doctors

Contact: Clinton Colmenares
Vanderbilt University Medical Center

Page: 1 2 3

Related biology news :

1. Hospitalization injuries prove costly to patients, health care system
2. For spinal cord injury patients, new insights for rehabilitation therapy
3. MIT sugars research affecting bypass patients, drug industry
4. Loss of the neuronal adhesion protein d-catenin leads to severe cognitive dysfunction
5. Cockroach-like robot leads new research effort
6. Washington University in St. Louis leads group studying aging process
7. Green tea research leads to gum and other products
8. Cancer drug resistance research leads to possible therapeutic target for Alzheimers disease
9. Research into cetacean reproduction leads to birth of killer whales by artificial insemination
10. UCSD finds genetic time bomb in heart that leads to heart failure in some patients
11. Meeting of the minds leads new era in fight against cancer

Post Your Comments:

(Date:8/23/2017)... ARMONK, N.Y. , Aug. 23, 2017  The general public,s help ... the human microbiome—the bacteria that live in and on the human body ... ... bacteria in the human microbiome, starting with the gut. The project's goal ... in disease. Photo credit: IBM ...
(Date:6/23/2017)... ARMONK, N.Y. and ITHACA, N.Y. ... IBM ) and Cornell University, a leader in dairy ... combined with bioinformatics designed to help reduce the chances ... breaches. With the onset of this dairy project, Cornell ... the Consortium for Sequencing the Food Supply Chain, a ...
(Date:5/16/2017)... --  Bridge Patient Portal , an enterprise patient ... Systems , an electronic medical record solutions developer ... a partnership to build an interface between the ... products, including Centricity Practice Solution (CPS), Centricity Business ... integrations will allow healthcare delivery networks using GE ...
Breaking Biology News(10 mins):
(Date:10/10/2017)... Angeles, CA (PRWEB) , ... ... ... Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, ... uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in ...
(Date:10/10/2017)... International research firm Parks Associates announced today that ... TMA 2017 Annual Meeting , October 11 in Scottsdale, ... security market and how smart safety and security products impact the competitive ... Parks Associates: Smart Home Devices: Main ... "The residential security market has experienced continued ...
(Date:10/10/2017)... ... October 10, 2017 , ... The Pittcon ... awards honoring scientists who have made outstanding contributions to analytical chemistry ... Pittcon 2018, the world’s leading conference and exposition for laboratory science, which will ...
(Date:10/9/2017)... (PRWEB) , ... October 09, 2017 , ... At its ... Dr. Christopher Stubbs, a professor in Harvard University’s Departments of Physics and Astronomy, has ... was a member of the winning team for the 2015 Breakthrough Prize in Fundamental ...
Breaking Biology Technology:
Cached News: